In 1985 Trouillet et al. (8) reported on the use of sugar (sucrose) for the treatment of acute mediastinitis following cardiac surgery. They treated 19 patients and followed a regimen of packing the cavities every 3 to 4 h with ordinary commercially available granular sugar. Near complete debridement of wounds was followed by the rapid formation of granulation tissue and eradication of bacterial infection after an average of 7.6 days. A similar regime had been used previously by Chirife et al. (4) .
Sugar was first used as a dressing at Northwick Park Hospital in 1982, when a paste formulation was developed (see Materials and Methods). Thick sugar paste has a consistency similar to that of modelling clay and can be packed into cavities with large openings, such as pressure sores. Thin sugar paste has a consistency similar to that of thin honey and is suitable for instillation into cavities with small openings. Polyethylene glycol (PEG) 400 was chosen as the lubricant because it does not interact with other components of the paste, is used in a wide variety of pharmaceutical preparations, and is relatively nontoxic (9) . It exerts antibacterial activity because it has a low water activity (2) . Hydrogen peroxide was added to the pastes as a preservative because they were packed into multidose ointment containers.
Sucrose pastes have been used clinically to treat infected and malodorous wounds. The pastes are safe to use in diabetic patients, as any sucrose that may be absorbed from a wound is excreted unchanged in the urine and does not affect diabetic control.
Microorganisms require water to grow and reproduce, and such water requirements are best defined in terms of water activity (a) of the substrate rather than as water concentration (3). The The final volume of paste and serum was 50 ml, and nutrient broth was used as the control. All were kept in stoppered conical flasks which were wrapped to exclude light. A 4-h broth culture of either S. aureus or P. mirabilis was diluted 10-fold with peptone water, and 0.5 ml of the resultant cell suspension was added to the paste-serum mixtures and control flasks. All flasks were incubated at 37°C for 130 min. Samples were taken at approximately 30-min intervals and serially diluted with peptone water for estimation of viable numbers. CLED agar was used for culturing P. mirabilis, and nutrient agar was used for culturing S. aureus. All plates were incubated at 37°C for 24 h, and the colonies were counted. A similar experiment was conducted with PEG 400 and S. aureus as a control without sugar and without hydrogen peroxide.
RESULTS
The pastes are chemically stable for at least 6 months with little loss of hydrogen peroxide if stored in screw-cap containers at 2 to 8°C. Sucrose in the thin paste does settle out after a few weeks of storage, but the paste can be readily reconstituted by stirring with a spatula before use.
The effects on a, of adding human serum to thin sucrose and xylose pastes are shown in Fig. 1 . This plot indicates that an aw of 0.86, the lowest a, at which S. aureus can proliferate (3), is achieved with a mixture containing approximately equal parts of paste and serum. Tables 2 and 3 sucrose and xylose pastes, with and without peroxide, with known numbers of microorganisms. In pastes with peroxide, the numbers of viable organisms declined rapidly, and none were detected 6 h after the initial inoculation. The pastes without peroxide exerted a less rapid bactericidal effect, and S. faecalis persisted for up to 168 h.
The effects of differing amounts of sucrose paste in blood agar on the growth of various microorganisms are shown in Table 4 . These results demonstrate that S. equisimilis was most easily inhibited, whereas S. aureus was the most resistant. Figures 2 and 3 show the effects of thin sucrose and xylose pastes, with and without hydrogen peroxide and various amounts of serum, on the viability of S. aureus. Viable mirabilis. The bactericidal effect of the pastes was more rapid than that observed against S. aureus. It appeared that the hydrogen peroxide made little contribution to the overall bactericidal effect. Figure 6 shows the effects of PEG 400, without hydrogen peroxide, on the viability of S. aureus. It demonstrates its bactericidal property, which occurs because it has an a, of 0. These results are similar to those of Chirife et al. (2) and are equivalent to those obtained with the sucrose and xylose pastes which contained only 32% PEG 400.
DISCUSSION
Chirife et al. (3) proposed that an important function of sucrose in a wound was to create an environment of low a, which inhibited and stressed bacterial growth. The formulation of sucrose paste and xylose paste had considerable effects in reducing aw, which suggested that these pastes would have antibacterial activity. This premise was confirmed when it was shown that sucrose paste in blood agar had a good antibacterial effect. It was noted, however, that S. aureus was the least inhibited, a result in keeping with the findings of Chirife et al. (3) , who demonstrated that a high concentration of sucrose (183 g/100 ml of water) was necessary to inhibit the growth of staphylococci.
The results of challenging the pastes with a variety of microorganisms indicate that all the pastes have good antibacterial activity, which is enhanced by the addition of 0.15% (vollwt) hydrogen peroxide.
The viability studies were performed on S. aureus and P. mirabilis because they are commonly found in infected wounds. In addition, S. aureus was demonstrated to grow in 30% sucrose in blood agar and thus presented the most severe challenge to the antimicrobial efficacy of the pastes.
The results indicated that P. mirabilis was very susceptible to the antibacterial activity of the pastes, which continued when they were diluted by 50%. The additional bacte- ricidal effect of peroxide may have been partly eliminated by the addition of serum, because of the well-described inactivation of hydrogen peroxide that occurs by organic matter.
These data also indicate that PEG 400 has good antimicrobial activity, but this compound could not be used alone as a wound treatment since it can be absorbed from a wound and may be nephrotoxic (9) . Our thick sucrose paste (18.5% PEG 400) and thin sucrose paste (32% PEG 400) have been used often in many elderly and frail patients over the past 8 years with no detectable adverse side effects, but we do advocate caution in its use in patients with renal failure.
Clinically we usually use sucrose pastes, primarily because sucrose is less expensive than xylose. Treatment regimens need to reflect our laboratory data and require frequent application of paste. When sucrose paste is added to a wound, it invariably dissolves in fluid drawn into its cavity, creating an environment of low a, which inhibits bacterial growth. As this dilution occurs within 3 to 4 h of addition of paste to the wound, repacking at least twice daily has been recommended. Although a, may not be maintained at less than 0.86 for more than 3 h after packing, clinical experience with sucrose paste has shown that twice-daily dressing is adequate to remove infected (and necrotic) slough from dirty wounds within a few days and to deodorize malodorous wounds.
The findings of this study indicate that sucrose and xylose pastes have good antimricrobial activities. In a controlled trial in a pig model, full thickness wounds (9 mm deep) Were packed with thick sucrose paste or gauze soaked in various antiseptic solutions (1) . The wounds were then packed and kept moist by covering with a semipermeable self-adhesive plastic film dressing (Opsite). The clinical and histological re'sults indicated that there was no difference between wounds lIeft unpacked but covered with Opsite and those packed with sucrose paste and covered with Opsite, whereas all'the wounds packed with gauze and an antiseptic showed evidence of delayed' healing. Tiis demonstrated that sugar paste neither inhibited or -tiliulated the normal cellular function of the wound healing process (1) . Our data indicates that sucrose paste may be of benefit for infected and malodorous wounds which traditionally are treated with antiseptics that can be toxic to granulation tissue.
